Literature DB >> 14727781

Does aggressive care following acute myocardial infarction reduce mortality? Analysis with instrumental variables to compare effectiveness in Canadian and United States patient populations.

Christine A Beck1, John Penrod, Theresa W Gyorkos, Stan Shapiro, Louise Pilote.   

Abstract

BACKGROUND: Previous U.S. studies suggest that the incremental ("marginal") use of the aggressive approach to care for acute myocardial infarction (AMI) in patients differing only in their distance to hospitals offering aggressive care may be associated with small mortality benefits. We hypothesized that the marginal benefits should be larger in Canada, as the country is operating on a lower margin because the approach to care is more conservative overall.
METHODS: This retrospective study used administrative data of hospital admissions and health services for all patients admitted for a first AMI in Quebec in 1988 (n = 8,674). We used differential distances to hospitals offering aggressive care as instrumental variables when measuring mortality up to four years after AMI.
RESULTS: Of the 4,422 subjects who were > or = 65 years old, 11 percent received cardiac catheterization within 90 days after admission. In a previous study that applied similar methodology to the 1987 U.S. Medicare population, 23 percent of subjects received catheterization within 90 days. As in the U.S. study, we found that subjects living closer to hospitals offering aggressive care were more likely to receive aggressive care than subjects living further away (26 percent versus 19 percent received cardiac catheterization within 90 days; 95 percent CI: 5 percent to 9 percent). Unlike the U.S. study, we found no differences in mortality across the "close" versus "far" differential distance groups (unadjusted differences at one year: 1 percent; 95 percent CI: -1 percent to 3 percent). This absence of association held in elderly (> or = 65 years) and younger age groups. Adjusted results also showed no differences between subjects receiving aggressive versus conservative care (at one year: 4 percent; 95 percent CI: -11 percent to 20 percent).
CONCLUSIONS: Contrary to our hypothesis, but consistent with results from numerous randomized trials and observational studies, we cannot confirm that, on the margin, the aggressive approach to post-AMI care is associated with mortality benefits in Canada.

Entities:  

Mesh:

Year:  2003        PMID: 14727781      PMCID: PMC1360957          DOI: 10.1111/j.1475-6773.2003.00186.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  28 in total

1.  Estimating the quality of care in hospitals using instrumental variables.

Authors:  G Gowrisankaran; R J Town
Journal:  J Health Econ       Date:  1999-12       Impact factor: 3.883

2.  An introduction to instrumental variables for epidemiologists.

Authors:  S Greenland
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

3.  Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction.

Authors:  A R Levy; R M Tamblyn; D Fitchett; P J McLeod; J A Hanley
Journal:  Can J Cardiol       Date:  1999-11       Impact factor: 5.223

4.  The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter?

Authors:  J M Brooks; M McClellan; H S Wong
Journal:  Inquiry       Date:  2000       Impact factor: 1.730

5.  Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.

Authors:  L Pilote; F Lavoie; V Ho; M J Eisenberg
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

6.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; E M Antman; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B Riegel; R O Russell; E E Smith; W D Weaver; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; A Garson; G Gregoratos; T J Ryan; S C Smith
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

7.  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

Authors: 
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

8.  Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography.

Authors:  Louise Pilote; Claude Lauzon; Thao Huynh; Danielle Dion; René Roux; Normand Racine; Suzanne Carignan; Jean G Diodati; Claude Lévesque; François Charbonneau; Joël Pouliot; Lawrence Joseph; Mark J Eisenberg
Journal:  Arch Intern Med       Date:  2002-03-11

9.  Cardiac procedure use and outcomes in elderly patients with acute myocardial infarction in the United States and Quebec, Canada, 1988 to 1994.

Authors:  Louise Pilote; Olga Saynina; Frederic Lavoie; Mark McClellan
Journal:  Med Care       Date:  2003-07       Impact factor: 2.983

10.  Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.

Authors:  M L Simoons; A E Arnold; A Betriu; D P de Bono; J Col; F C Dougherty; R von Essen; H Lambertz; J Lubsen; B Meier
Journal:  Lancet       Date:  1988-01-30       Impact factor: 79.321

View more
  8 in total

1.  Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches.

Authors:  John M Brooks; Christopher P Irwin; Lawrence G Hunsicker; Michael J Flanigan; Elizabeth A Chrischilles; Jane F Pendergast
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

2.  Effect of evidence-based acute pain management practices on inpatient costs.

Authors:  John M Brooks; Marita G Titler; Gail Ardery; Keela Herr
Journal:  Health Serv Res       Date:  2009-02       Impact factor: 3.402

3.  The Reliability of Instrumental Variables in Health Care Effectiveness Research: Less Is More.

Authors:  Stephen B Soumerai; Ross Koppel
Journal:  Health Serv Res       Date:  2016-07-21       Impact factor: 3.402

4.  Association between stroke center hospitalization for acute ischemic stroke and mortality.

Authors:  Ying Xian; Robert G Holloway; Paul S Chan; Katia Noyes; Manish N Shah; Henry H Ting; Andre R Chappel; Eric D Peterson; Bruce Friedman
Journal:  JAMA       Date:  2011-01-26       Impact factor: 56.272

Review 5.  Use of instrumental variable in prescription drug research with observational data: a systematic review.

Authors:  Yong Chen; Becky A Briesacher
Journal:  J Clin Epidemiol       Date:  2010-12-16       Impact factor: 6.437

6.  Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009.

Authors:  Carolyn J Presley; Pamela R Soulos; Jeph Herrin; Kenneth B Roberts; James B Yu; Brigid Killelea; Beth-Ann Lesnikoski; Jessica B Long; Cary P Gross
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

7.  PRODUCTIVITY SPILLOVERS IN HEALTHCARE: EVIDENCE FROM THE TREATMENT OF HEART ATTACKS.

Authors:  Amitabh Chandra; Douglas O Staiger
Journal:  J Polit Econ       Date:  2007

8.  The relationship between hospital volume and mortality in mechanical ventilation: an instrumental variable analysis.

Authors:  Jeremy M Kahn; Thomas R Ten Have; Theodore J Iwashyna
Journal:  Health Serv Res       Date:  2009-03-17       Impact factor: 3.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.